Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 1264 entries
Sorted by: Best Match Show Resources per page
The effect of modified-live virus vaccination on von Willebrand factor antigen concentrations and platelet counts in dogs.

Veterinary clinical pathology

Stokol T, Parry BW.
PMID: 12658592
Vet Clin Pathol. 1997;26(3):135-137. doi: 10.1111/j.1939-165x.1997.tb00725.x.

No abstract available.

Cite
Stokol T, Parry BW. The effect of modified-live virus vaccination on von Willebrand factor antigen concentrations and platelet counts in dogs. Vet Clin Pathol. 1997;26(3):135-137doi: 10.1111/j.1939-165x.1997.tb00725.x.
Stokol, T., & Parry, B. W. (1997). The effect of modified-live virus vaccination on von Willebrand factor antigen concentrations and platelet counts in dogs. Veterinary clinical pathology, 26(3), 135-137. https://doi.org/10.1111/j.1939-165x.1997.tb00725.x
Stokol, Tracy, and Parry, Bruce W.. "The effect of modified-live virus vaccination on von Willebrand factor antigen concentrations and platelet counts in dogs." Veterinary clinical pathology vol. 26,3 (1997): 135-137. doi: https://doi.org/10.1111/j.1939-165x.1997.tb00725.x
Stokol T, Parry BW. The effect of modified-live virus vaccination on von Willebrand factor antigen concentrations and platelet counts in dogs. Vet Clin Pathol. 1997;26(3):135-137. doi: 10.1111/j.1939-165x.1997.tb00725.x. PMID: 12658592.
Copy Download .nbib Format: NLM
[Effects of carvedilol on circulating levels of endothelin and von Willebrand factor in patients with unstable angina pectoris].

Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences

Wang GB, Hu SJ, Sun J.
PMID: 12601881
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2002 Aug;31(5):340-343. doi: 10.3785/j.issn.1008-9292.2002.05.007.

OBJECTIVE: To observe the effect of carvedilol on circulating levels of endothelin (ET) and von Willebrand factor (vWF) in patients with unstable angina pectoris (UAP). METHODS Forty patients with UAP were randomly divided into two groups. On the basis...

Cite
Wang GB, Hu SJ, Sun J. [Effects of carvedilol on circulating levels of endothelin and von Willebrand factor in patients with unstable angina pectoris]. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2002;31(5):340-343doi: 10.3785/j.issn.1008-9292.2002.05.007.
Wang, G. B., Hu, S. J., & Sun, J. (2002). [Effects of carvedilol on circulating levels of endothelin and von Willebrand factor in patients with unstable angina pectoris]. Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences, 31(5), 340-343. https://doi.org/10.3785/j.issn.1008-9292.2002.05.007
Wang, Guo-Bin, et al. "[Effects of carvedilol on circulating levels of endothelin and von Willebrand factor in patients with unstable angina pectoris]." Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences vol. 31,5 (2002): 340-343. doi: https://doi.org/10.3785/j.issn.1008-9292.2002.05.007
Wang GB, Hu SJ, Sun J. [Effects of carvedilol on circulating levels of endothelin and von Willebrand factor in patients with unstable angina pectoris]. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2002 Aug;31(5):340-343. doi: 10.3785/j.issn.1008-9292.2002.05.007. Chinese. PMID: 12601881.
Copy Download .nbib Format: NLM
Azithromycin therapy in patients with chronic Chlamydia pneumoniae infection and coronary heart disease: immediate and long-term effects on inflammation, coagulation, and lipid status in a double-blind, placebo-controlled study.

European journal of internal medicine

Gabriel AS, Ahnve S, Gnarpe H, Gnarpe J, Martinsson A.
PMID: 14962698
Eur J Intern Med. 2003 Dec;14(8):470-478. doi: 10.1016/j.ejim.2003.07.001.

Background: An association between Chlamydia pneumoniae (Cp) infection and coronary heart disease (CHD) has already been reported. We investigated the relationship between Cp infection and other risk factors in CHD patients, as well as the effects of azithromycin treatment....

Cite
Gabriel AS, Ahnve S, Gnarpe H, et al. Azithromycin therapy in patients with chronic Chlamydia pneumoniae infection and coronary heart disease: immediate and long-term effects on inflammation, coagulation, and lipid status in a double-blind, placebo-controlled study. Eur J Intern Med. 2003;14(8):470-478doi: 10.1016/j.ejim.2003.07.001.
Gabriel, A. S., Ahnve, S., Gnarpe, H., Gnarpe, J., & Martinsson, A. (2003). Azithromycin therapy in patients with chronic Chlamydia pneumoniae infection and coronary heart disease: immediate and long-term effects on inflammation, coagulation, and lipid status in a double-blind, placebo-controlled study. European journal of internal medicine, 14(8), 470-478. https://doi.org/10.1016/j.ejim.2003.07.001
Gabriel, Amon S., et al. "Azithromycin therapy in patients with chronic Chlamydia pneumoniae infection and coronary heart disease: immediate and long-term effects on inflammation, coagulation, and lipid status in a double-blind, placebo-controlled study." European journal of internal medicine vol. 14,8 (2003): 470-478. doi: https://doi.org/10.1016/j.ejim.2003.07.001
Gabriel AS, Ahnve S, Gnarpe H, Gnarpe J, Martinsson A. Azithromycin therapy in patients with chronic Chlamydia pneumoniae infection and coronary heart disease: immediate and long-term effects on inflammation, coagulation, and lipid status in a double-blind, placebo-controlled study. Eur J Intern Med. 2003 Dec;14(8):470-478. doi: 10.1016/j.ejim.2003.07.001. PMID: 14962698.
Copy Download .nbib Format: NLM
von Willebrand Factor in CHD and stroke: relationships and therapeutic implications.

Current treatment options in cardiovascular medicine

Cooney MT, Dudina AL, O'Callaghan P, Graham IM.
PMID: 17601381
Curr Treat Options Cardiovasc Med. 2007 Jun;9(3):180-90. doi: 10.1007/s11936-007-0011-8.

Atherosclerotic cardiovascular disease (CVD), which includes coronary heart disease (CHD) and stroke, is now the most common cause of death in the middle aged and elderly in all parts of the world except subSaharan Africa. The direct cause of...

Cite
Cooney MT, Dudina AL, O'Callaghan P, et al. von Willebrand Factor in CHD and stroke: relationships and therapeutic implications. Curr Treat Options Cardiovasc Med. 2007;9(3):180-90doi: 10.1007/s11936-007-0011-8.
Cooney, M. T., Dudina, A. L., O'Callaghan, P., & Graham, I. M. (2007). von Willebrand Factor in CHD and stroke: relationships and therapeutic implications. Current treatment options in cardiovascular medicine, 9(3), 180-90. https://doi.org/10.1007/s11936-007-0011-8
Cooney, Marie-Therese, et al. "von Willebrand Factor in CHD and stroke: relationships and therapeutic implications." Current treatment options in cardiovascular medicine vol. 9,3 (2007): 180-90. doi: https://doi.org/10.1007/s11936-007-0011-8
Cooney MT, Dudina AL, O'Callaghan P, Graham IM. von Willebrand Factor in CHD and stroke: relationships and therapeutic implications. Curr Treat Options Cardiovasc Med. 2007 Jun;9(3):180-90. doi: 10.1007/s11936-007-0011-8. PMID: 17601381.
Copy Download .nbib Format: NLM
Recombinant clotting factors: a review of current clinical status.

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy

Lusher JM.
PMID: 18034535
BioDrugs. 2000 Apr;13(4):289-98. doi: 10.2165/00063030-200013040-00007.

In the short time span since the cloning of the human genes for factors VIII, IX and VII, recombinant factor (rF)VIII, rFIX and rFVIIa concentrates have been produced and standardised, have entered clinical trials, and have been licensed for...

Cite
Lusher JM. Recombinant clotting factors: a review of current clinical status. BioDrugs. 2000;13(4):289-98doi: 10.2165/00063030-200013040-00007.
Lusher, J. M. (2000). Recombinant clotting factors: a review of current clinical status. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy, 13(4), 289-98. https://doi.org/10.2165/00063030-200013040-00007
Lusher, J M. "Recombinant clotting factors: a review of current clinical status." BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy vol. 13,4 (2000): 289-98. doi: https://doi.org/10.2165/00063030-200013040-00007
Lusher JM. Recombinant clotting factors: a review of current clinical status. BioDrugs. 2000 Apr;13(4):289-98. doi: 10.2165/00063030-200013040-00007. PMID: 18034535.
Copy Download .nbib Format: NLM
Improved method of ink-gelatin perfusion for visualising rat retinal microvessels.

Acta histochemica et cytochemica

Jianbin T, Liang H, Jufang H, Hui W, Dan C, Leping Z, Jin Z, Xuegang L.
PMID: 18989466
Acta Histochem Cytochem. 2008 Oct 29;41(5):127-33. doi: 10.1267/ahc.08015. Epub 2008 Aug 26.

To visualize completely rat retinal microvessels, the gelatin-ink perfusion condition was systematically optimized using von Willebrand factor (vWf) immunostaining as control. Whether the vessel showed by the new perfusion condition can be used for double label with neurons or...

Cite
Jianbin T, Liang H, Jufang H, et al. Improved method of ink-gelatin perfusion for visualising rat retinal microvessels. Acta Histochem Cytochem. 2008;41(5):127-33doi: 10.1267/ahc.08015.
Jianbin, T., Liang, H., Jufang, H., Hui, W., Dan, C., Leping, Z., Jin, Z., & Xuegang, L. (2008). Improved method of ink-gelatin perfusion for visualising rat retinal microvessels. Acta histochemica et cytochemica, 41(5), 127-33. https://doi.org/10.1267/ahc.08015
Jianbin, Tong, et al. "Improved method of ink-gelatin perfusion for visualising rat retinal microvessels." Acta histochemica et cytochemica vol. 41,5 (2008): 127-33. doi: https://doi.org/10.1267/ahc.08015
Jianbin T, Liang H, Jufang H, Hui W, Dan C, Leping Z, Jin Z, Xuegang L. Improved method of ink-gelatin perfusion for visualising rat retinal microvessels. Acta Histochem Cytochem. 2008 Oct 29;41(5):127-33. doi: 10.1267/ahc.08015. Epub 2008 Aug 26. PMID: 18989466; PMCID: PMC2576503.
Copy Download .nbib Format: NLM
Activated platelets mediate Staphylococcus aureus deposition on subendothelial extracellular matrix: the role of glycoprotein Ib.

Platelets

Shenkman B, Rubinstein E, Dardik R, Tamarin I, Savion N, Varon D.
PMID: 16801069
Platelets. 1999;10(1):36-44. doi: 10.1080/09537109976338.

Extracellular matrix (ECM) derived from bovine corneal endothelial cells was used as a model to study the role of platelets in Staphylococcus aureus interaction with the vascular subendothelium. In whole blood, S. aureus activated platelets, as demonstrated by P-selectin...

Cite
Shenkman B, Rubinstein E, Dardik R, et al. Activated platelets mediate Staphylococcus aureus deposition on subendothelial extracellular matrix: the role of glycoprotein Ib. Platelets. 1999;10(1):36-44doi: 10.1080/09537109976338.
Shenkman, B., Rubinstein, E., Dardik, R., Tamarin, I., Savion, N., & Varon, D. (1999). Activated platelets mediate Staphylococcus aureus deposition on subendothelial extracellular matrix: the role of glycoprotein Ib. Platelets, 10(1), 36-44. https://doi.org/10.1080/09537109976338
Shenkman, B, et al. "Activated platelets mediate Staphylococcus aureus deposition on subendothelial extracellular matrix: the role of glycoprotein Ib." Platelets vol. 10,1 (1999): 36-44. doi: https://doi.org/10.1080/09537109976338
Shenkman B, Rubinstein E, Dardik R, Tamarin I, Savion N, Varon D. Activated platelets mediate Staphylococcus aureus deposition on subendothelial extracellular matrix: the role of glycoprotein Ib. Platelets. 1999;10(1):36-44. doi: 10.1080/09537109976338. PMID: 16801069.
Copy Download .nbib Format: NLM
Increased platelet activation in renal transplant patients.

Platelets

Taylor JE, Porter C, Heptinstall S, McLaren M, Belch JJ.
PMID: 16801096
Platelets. 1999 Jul;10(4):223-7. doi: 10.1080/09537109976068.

BACKGROUND: Patients with functioning renal transplants are at risk of graft thrombosis in the postoperative period, and of fistula thrombosis and other thrombotic events thereafter. Investigation and therapeutic manipulation of haemostasis in these patients offers a means to counter...

Cite
Taylor JE, Porter C, Heptinstall S, et al. Increased platelet activation in renal transplant patients. Platelets. 1999;10(4):223-7doi: 10.1080/09537109976068.
Taylor, J. E., Porter, C., Heptinstall, S., McLaren, M., & Belch, J. J. (1999). Increased platelet activation in renal transplant patients. Platelets, 10(4), 223-7. https://doi.org/10.1080/09537109976068
Taylor, J E, et al. "Increased platelet activation in renal transplant patients." Platelets vol. 10,4 (1999): 223-7. doi: https://doi.org/10.1080/09537109976068
Taylor JE, Porter C, Heptinstall S, McLaren M, Belch JJ. Increased platelet activation in renal transplant patients. Platelets. 1999 Jul;10(4):223-7. doi: 10.1080/09537109976068. PMID: 16801096.
Copy Download .nbib Format: NLM
Angiogenesis in histologically benign squamous mucosa is a sensitive marker for nearby cervical intraepithelial neoplasia.

Angiogenesis

Smith-McCune KK, Zhu Y, Darragh T.
PMID: 14517469
Angiogenesis. 1998;2(2):135-42. doi: 10.1023/a:1009236421900.

Cervical intraepithelial neoplasia (CIN) lesions elicit a neovascularization response at the stromal-epithelial junction. In this study, the angiogenic properties of histologically benign cervical epithelium adjacent to CIN were compared to samples of normal cervix from patients with no evidence...

Cite
Smith-McCune KK, Zhu Y, Darragh T. Angiogenesis in histologically benign squamous mucosa is a sensitive marker for nearby cervical intraepithelial neoplasia. Angiogenesis. 1998;2(2):135-42doi: 10.1023/a:1009236421900.
Smith-McCune, K. K., Zhu, Y., & Darragh, T. (1998). Angiogenesis in histologically benign squamous mucosa is a sensitive marker for nearby cervical intraepithelial neoplasia. Angiogenesis, 2(2), 135-42. https://doi.org/10.1023/a:1009236421900
Smith-McCune, K K, et al. "Angiogenesis in histologically benign squamous mucosa is a sensitive marker for nearby cervical intraepithelial neoplasia." Angiogenesis vol. 2,2 (1998): 135-42. doi: https://doi.org/10.1023/a:1009236421900
Smith-McCune KK, Zhu Y, Darragh T. Angiogenesis in histologically benign squamous mucosa is a sensitive marker for nearby cervical intraepithelial neoplasia. Angiogenesis. 1998;2(2):135-42. doi: 10.1023/a:1009236421900. PMID: 14517469.
Copy Download .nbib Format: NLM
Computational aspects of protein functionality.

Comparative and functional genomics

Paton RC, Toh CH.
PMID: 18629033
Comp Funct Genomics. 2004;5(1):85-90. doi: 10.1002/cfg.360.

The purpose of this short article is to examine certain aspects of protein functionality with relation to some key organizing ideas. This is important from a computational viewpoint in order to take account of modelling both biological systems and...

Cite
Paton RC, Toh CH. Computational aspects of protein functionality. Comp Funct Genomics. 2004;5(1):85-90doi: 10.1002/cfg.360.
Paton, R. C., & Toh, C. H. (2004). Computational aspects of protein functionality. Comparative and functional genomics, 5(1), 85-90. https://doi.org/10.1002/cfg.360
Paton, R C, and Toh, C-H. "Computational aspects of protein functionality." Comparative and functional genomics vol. 5,1 (2004): 85-90. doi: https://doi.org/10.1002/cfg.360
Paton RC, Toh CH. Computational aspects of protein functionality. Comp Funct Genomics. 2004;5(1):85-90. doi: 10.1002/cfg.360. PMID: 18629033; PMCID: PMC2447316.
Copy Download .nbib Format: NLM
Analysis of megadalton ions using cryodetection MALDI time-of-flight mass spectrometry.

Analytical chemistry

Wenzel RJ, Matter U, Schultheis L, Zenobi R.
PMID: 16013843
Anal Chem. 2005 Jul 15;77(14):4329-37. doi: 10.1021/ac0482054.

Presented are initial results from the first commercially available matrix-assisted laser desorption/ionization time-of-flight mass spectrometer specifically designed for the sensitive detection of very high mass ions (macromizer, Comet AG). This new instrument utilizes a 16-element superconducting tunnel junction detector...

Cite
Wenzel RJ, Matter U, Schultheis L, et al. Analysis of megadalton ions using cryodetection MALDI time-of-flight mass spectrometry. Anal Chem. 2005;77(14):4329-37doi: 10.1021/ac0482054.
Wenzel, R. J., Matter, U., Schultheis, L., & Zenobi, R. (2005). Analysis of megadalton ions using cryodetection MALDI time-of-flight mass spectrometry. Analytical chemistry, 77(14), 4329-37. https://doi.org/10.1021/ac0482054
Wenzel, Ryan J, et al. "Analysis of megadalton ions using cryodetection MALDI time-of-flight mass spectrometry." Analytical chemistry vol. 77,14 (2005): 4329-37. doi: https://doi.org/10.1021/ac0482054
Wenzel RJ, Matter U, Schultheis L, Zenobi R. Analysis of megadalton ions using cryodetection MALDI time-of-flight mass spectrometry. Anal Chem. 2005 Jul 15;77(14):4329-37. doi: 10.1021/ac0482054. PMID: 16013843.
Copy Download .nbib Format: NLM
Age related elevation of serum macrophage colony stimulating factor (M-CSF) level.

Archives of gerontology and geriatrics

Suehiro A, Imagawa T, Hosokawa H, Suehiro M, Ohe Y, Kakishita E.
PMID: 15374073
Arch Gerontol Geriatr. 1999 Jul-Aug;29(1):13-20. doi: 10.1016/s0167-4943(99)00015-1.

We recently reported that the serum level of macrophage colony-stimulating factor (M-CSF) was elevated in patients with cerebral infarction. In the present study, we measured serum M-CSF level, as well as coagulo-fibrinolytic markers and general laboratory tests in adult...

Cite
Suehiro A, Imagawa T, Hosokawa H, et al. Age related elevation of serum macrophage colony stimulating factor (M-CSF) level. Arch Gerontol Geriatr. 1999;29(1):13-20doi: 10.1016/s0167-4943(99)00015-1.
Suehiro, A., Imagawa, T., Hosokawa, H., Suehiro, M., Ohe, Y., & Kakishita, E. (1999). Age related elevation of serum macrophage colony stimulating factor (M-CSF) level. Archives of gerontology and geriatrics, 29(1), 13-20. https://doi.org/10.1016/s0167-4943(99)00015-1
Suehiro, A, et al. "Age related elevation of serum macrophage colony stimulating factor (M-CSF) level." Archives of gerontology and geriatrics vol. 29,1 (1999): 13-20. doi: https://doi.org/10.1016/s0167-4943(99)00015-1
Suehiro A, Imagawa T, Hosokawa H, Suehiro M, Ohe Y, Kakishita E. Age related elevation of serum macrophage colony stimulating factor (M-CSF) level. Arch Gerontol Geriatr. 1999 Jul-Aug;29(1):13-20. doi: 10.1016/s0167-4943(99)00015-1. PMID: 15374073.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 1264 entries